DA Schwartz, RA Helmers, JR Galvin, DS Van Fossen, KL Frees, CS Dayton, LF Burmeister and GW Hunninghake
Department of Internal Medicine, Department of Veterans Administration Medical Center, Iowa City, Iowa.

To identify the determinants of survival in patients with idiopathic pulmonary fibrosis (IPF), we performed a survival analysis on 74 subjects with IPF. The study subjects were on average 64 yr of age (range, 25 to 83 yr), 62% were male, and 29% were never smokers. A tissue diagnosis was made in 67 (91%) of our study subjects. These subjects were followed for a mean period of 4 yr (range, 1.4 to 118.8 months) after the onset of pulmonary symptoms. During the period of observation, 41 subjects died (median survival = 28.2 months) and 33 continue to survive (median follow-up period = 60.9 months). A univariate analysis demonstrated that diminished survival was significantly associated with male gender (hazard ratio = 1.98; 95% confidence interval [CI] = 1.01-3.85), a higher FEV1/FVC ratio (hazard ratio = 1.82 [per 10% increase in the FEV1/FVC ratio]; 95% CI = 1.21- 2.73), a lower percent predicted FVC (hazard ratio = 0.74; 95% CI = 0.60-0.91), a lower percent predicted total lung capacity (TLC) (hazard ratio = 0.75; 95% CI = 0.60-0.94), a lower percent predicted diffusing capacity of carbon monoxide (DLCO) (hazard ratio = 0.69; 95% CI = 0.53- 0.89), a higher ILO profusion category on chest radiograph (hazard ratio = 3.52; 95% CI = 1.58-7.87), and an enhanced release of prostaglandin E2 (PGE2) by cultured alveolar macrophages (hazard ratio = 1.32 [per 10 pm/ml of PGE2]; 95% CI = 1.07-1.62).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al. Sex differences in physiological progression of idiopathic pulmonary fibrosis Eur. Respir. J., June 1, 2008; 31(6): 1183 - 1188. [Abstract] [Full Text] [PDF]

				B. W. Kinder, K. K. Brown, M. I. Schwarz, J. H. Ix, A. Kervitsky, and T. E. King Jr Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis Chest, January 1, 2008; 133(1): 226 - 232. [Abstract] [Full Text] [PDF]

				R. Hyzy, S. Huang, J. Myers, K. Flaherty, and F. Martinez Acute Exacerbation of Idiopathic Pulmonary Fibrosis Chest, November 1, 2007; 132(5): 1652 - 1658. [Abstract] [Full Text] [PDF]

				A. U Wells, A. G Nicholson, and D. M Hansell Challenges in pulmonary fibrosis {middle dot} 4: Smoking-induced diffuse interstitial lung diseases Thorax, October 1, 2007; 62(10): 904 - 910. [Abstract] [Full Text] [PDF]

				R. M Rudd, R. J Prescott, J C Chalmers, I. D A Johnston, and for the Fibrosing Alveolitis Subcommittee of the R British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival Thorax, January 1, 2007; 62(1): 62 - 66. [Abstract] [Full Text] [PDF]

				J Gribbin, R B Hubbard, I Le Jeune, C J P Smith, J West, and L J Tata Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax, November 1, 2006; 61(11): 980 - 985. [Abstract] [Full Text] [PDF]

				G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster Incidence and Prevalence of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 810 - 816. [Abstract] [Full Text] [PDF]

				D. J. Lederer, S. M. Arcasoy, J. S. Wilt, F. D'Ovidio, J. R. Sonett, and S. M. Kawut Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 659 - 664. [Abstract] [Full Text] [PDF]

				C. J. Lettieri, S. D. Nathan, S. D. Barnett, S. Ahmad, and A. F. Shorr Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis Chest, March 1, 2006; 129(3): 746 - 752. [Abstract] [Full Text] [PDF]

				G. Raghu, S. T.-Y. Yang, C. Spada, J. Hayes, and C. A. Pellegrini Sole Treatment of Acid Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: A Case Series Chest, March 1, 2006; 129(3): 794 - 800. [Abstract] [Full Text] [PDF]

				M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al. High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis. N. Engl. J. Med., November 24, 2005; 353(21): 2229 - 2242. [Abstract] [Full Text] [PDF]

				K. R. F. M.D. and G. G. Hunninghake Smoking: An Injury with Many Lung Manifestations Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1070 - 1071. [Full Text] [PDF]

				M. P. Steele, M. C. Speer, J. E. Loyd, K. K. Brown, A. Herron, S. H. Slifer, L. H. Burch, M. M. Wahidi, J. A. Phillips III, T. A. Sporn, et al. Clinical and Pathologic Features of Familial Interstitial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1146 - 1152. [Abstract] [Full Text] [PDF]

				D. Bouros and K. M. Antoniou Current and future therapeutic approaches in idiopathic pulmonary fibrosis Eur. Respir. J., October 1, 2005; 26(4): 693 - 703. [Abstract] [Full Text] [PDF]

				H. F. Nadrous, P. A. Pellikka, M. J. Krowka, K. L. Swanson, N. Chaowalit, P. A. Decker, and J. H. Ryu Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis Chest, October 1, 2005; 128(4): 2393 - 2399. [Abstract] [Full Text] [PDF]

				M. A Pacanowski and G. W Amsden Interferon Gamma-1b in the Treatment of Idiopathic Pulmonary Fibrosis Ann. Pharmacother., October 1, 2005; 39(10): 1678 - 1686. [Abstract] [Full Text] [PDF]

				M. Gharaee-Kermani, K. Hatano, Y. Nozaki, and S. H. Phan Gender-Based Differences in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., June 1, 2005; 166(6): 1593 - 1606. [Abstract] [Full Text] [PDF]

				T. Eaton, P. Young, D. Milne, and A. U. Wells Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1150 - 1157. [Abstract] [Full Text] [PDF]

				J J Egan, F J Martinez, A U Wells, and T Williams Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification Thorax, April 1, 2005; 60(4): 270 - 273. [Full Text] [PDF]

				S. D. Nathan Lung Transplantation: Disease-Specific Considerations for Referral Chest, March 1, 2005; 127(3): 1006 - 1016. [Abstract] [Full Text] [PDF]

				T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Eur. Respir. J., January 1, 2005; 25(1): 96 - 103. [Abstract] [Full Text] [PDF]

				H. R. Collard, J. H. Ryu, W. W. Douglas, M. I. Schwarz, D. Curran-Everett, T. E. King Jr., and K. K. Brown Combined Corticosteroid and Cyclophosphamide Therapy Does Not Alter Survival in Idiopathic Pulmonary Fibrosis Chest, June 1, 2004; 125(6): 2169 - 2174. [Abstract] [Full Text] [PDF]

				G. Raghu, K. K. Brown, W. Z. Bradford, K. Starko, P. W. Noble, D. A. Schwartz, T. E. King Jr., and the Idiopathic Pulmonary Fibrosis Study Group A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis N. Engl. J. Med., January 8, 2004; 350(2): 125 - 133. [Abstract] [Full Text] [PDF]

				N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]

				H. R. Collard, T. E. King Jr., B. B. Bartelson, J. S. Vourlekis, M. I. Schwarz, and K. K. Brown Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 538 - 542. [Abstract] [Full Text] [PDF]

				K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross, T. V. Colby, W. D. Travis, A. Flint, G. B. Toews, J. P. Lynch III, et al. Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 543 - 548. [Abstract] [Full Text] [PDF]

				P. I. Latsi, R. M. du Bois, A. G. Nicholson, T. V. Colby, D. Bisirtzoglou, A. Nikolakopoulou, S. Veeraraghavan, D. M. Hansell, and A. U. Wells Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 531 - 537. [Abstract] [Full Text] [PDF]

				S. Veeraraghavan, P.I. Latsi, A.U. Wells, P. Pantelidis, A.G. Nicholson, T.V. Colby, P.L. Haslam, E.A. Renzoni, and R.M. du Bois BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia Eur. Respir. J., August 1, 2003; 22(2): 239 - 244. [Abstract] [Full Text] [PDF]

				A. U. Wells, S. R. Desai, M. B. Rubens, N. S. L. Goh, D. Cramer, A. G. Nicholson, T. V. Colby, R. M. du Bois, and D. M. Hansell Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 962 - 969. [Abstract] [Full Text] [PDF]

				F. H.Y. Green Overview of Pulmonary Fibrosis Chest, December 1, 2002; 122(6_suppl): 334S - 339S. [Abstract] [Full Text] [PDF]

				K. Watanabe, K. Higuchi, K. Ninomiya, T. Ohshima, T. Aritomi, Y. Kawabata, and M. Yoshida Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia Eur. Respir. J., November 1, 2002; 20(5): 1213 - 1219. [Abstract] [Full Text] [PDF]

				G. Saydain, A. Islam, B. Afessa, J. H. Ryu, J. P. Scott, and S. G. Peters Outcome of Patients with Idiopathic Pulmonary Fibrosis Admitted to the Intensive Care Unit Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 839 - 842. [Abstract] [Full Text]

				M. Selman From Anti-inflammatory Drugs Through Antifibrotic Agents to Lung Transplantation : A Long Road of Research, Clinical Attempts, and Failures in the Treatment of Idiopathic Pulmonary Fibrosis Chest, September 1, 2002; 122(3): 759 - 761. [Full Text] [PDF]

				S. J. Timmer, A. M. Karamzadeh, G.L. Yung, J. Kriett, S. W. Jamieson, and C. M. Smith Predicting Survival of Lung Transplantation Candidates With Idiopathic Interstitial Pneumonia* : Does PaO2 Predict Survival? Chest, September 1, 2002; 122(3): 779 - 784. [Abstract] [Full Text] [PDF]

				H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis Thorax, July 1, 2002; 57(7): 623 - 628. [Abstract] [Full Text] [PDF]

				R. Hubbard and A. Venn The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis Rheumatology, June 1, 2002; 41(6): 676 - 679. [Abstract] [Full Text] [PDF]

				M. R. Khoshnevis, T. E. King Jr., and J. Tooze Histopathology and prediction of survival in usual interstitial pneumonia Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1451 - 1452. [Full Text] [PDF]

				K.E. Greene, T.E. King Jr, Y. Kuroki, B. Bucher-Bartelson, G.W. Hunninghake, L.S. Newman, H. Nagae, and R.J. Mason Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Eur. Respir. J., March 1, 2002; 19(3): 439 - 446. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304. [Full Text] [PDF]

				M.J. Thomeer, B. Dehaes, L. Mortelmans, and M. Demedts Pertechnegas lung clearance in different forms of interstitial lung disease Eur. Respir. J., January 1, 2002; 19(1): 31 - 36. [Abstract] [Full Text] [PDF]

				N Mogulkoc, M H Brutsche, P W Bishop, B Murby, M S Greaves, A W Horrocks, M Wilson, C McCullough, M Prescott, and J J Egan Pulmonary 99mTc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP) Thorax, December 1, 2001; 56(12): 916 - 923. [Abstract] [Full Text] [PDF]

				T. E. KING JR., J. A. TOOZE, M. I. SCHWARZ, K. R. BROWN, and R. M. CHERNIACK Predicting Survival in Idiopathic Pulmonary Fibrosis . Scoring System and Survival Model Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1171 - 1181. [Abstract] [Full Text] [PDF]

				T. E. KING JR., M. I. SCHWARZ, K. BROWN, J. A. TOOZE, T. V. COLBY, J. A. WALDRON JR., A. FLINT, W. THURLBECK, and R. M. CHERNIACK Idiopathic Pulmonary Fibrosis . Relationship between Histopathologic Features and Mortality Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1025 - 1032. [Abstract] [Full Text] [PDF]

				T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF]

				N. MOGULKOC, M. H. BRUTSCHE, P. W. BISHOP, S. M. GREAVES, A. W. HORROCKS, and J. J. EGAN Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 103 - 108. [Abstract] [Full Text] [PDF]

				R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]

				M. Selman, T. E. King Jr., and A. Pardo Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med, January 16, 2001; 134(2): 136 - 151. [Abstract] [Full Text] [PDF]

				A. G. NICHOLSON, T. V. COLBY, R. M. DUBOIS, D. M. HANSELL, and A. U. WELLS The Prognostic Significance of the Histologic Pattern of Interstitial Pneumonia in Patients Presenting with the Clinical Entity of Cryptogenic Fibrosing Alveolitis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2213 - 2217. [Abstract] [Full Text]

				J. E. Michaelson, S. M. Aguayo, and J. Roman Idiopathic Pulmonary Fibrosis : A Practical Approach for Diagnosis and Management Chest, September 1, 2000; 118(3): 788 - 794. [Full Text] [PDF]

				H. TAKAHASHI, T. FUJISHIMA, H. KOBA, S. MURAKAMI, K. KUROKAWA, Y. SHIBUYA, M. SHIRATORI, Y. KUROKI, and S. ABE Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1109 - 1114. [Abstract] [Full Text]

				D. A. Zisman, J. P. Lynch III, G. B. Toews, E. A. Kazerooni, A. Flint, and F. J. Martinez Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis : A Prospective Study in Patients Who Failed To Respond to Corticosteroids Chest, June 1, 2000; 117(6): 1619 - 1626. [Abstract] [Full Text] [PDF]

				A. PARDO, R. BARRIOS, M. GAXIOLA, L. SEGURA-VALDEZ, G. CARRILLO, A. ESTRADA, M. MEJÍA, and M. SELMAN Increase of Lung Neutrophils in Hypersensitivity Pneumonitis Is Associated with Lung Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1698 - 1704. [Abstract] [Full Text]

				W. W. DOUGLAS, J. H. RYU, and D. R. SCHROEDER Idiopathic Pulmonary Fibrosis . Impact of Oxygen and Colchicine, Prednisone, or No Therapy on Survival Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1172 - 1178. [Abstract] [Full Text]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				R. J. MASON, M. I. SCHWARZ, G. W. HUNNINGHAKE, and R. A. MUSSON Pharmacological Therapy for Idiopathic Pulmonary Fibrosis . Past, Present, and Future Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1771 - 1777. [Full Text]

				D. M Mitchell and A. Woodcock Introduction Thorax, August 1, 1999; 54(90002): S1 - 1. [PDF]

				A. XAUBET, C. AGUSTI, P. LUBURICH, J. ROCA, C. MONTON, M. C. AYUSO, J. A. BARBERA, and R. RODRIGUEZ-ROISIN Pulmonary Function Tests and CT Scan in the Management of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 431 - 436. [Abstract] [Full Text] [PDF]

				International Guidelines for the Selection of Lung Transplant Candidates Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 335 - 339. [Full Text] [PDF]

				D. W Mapel, W. C Hunt, R. Utton, K. B Baumgartner, J. M Samet, and D. B Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax, June 1, 1998; 53(6): 469 - 476. [Abstract] [Full Text]

				S. E. GAY, E. A. KAZEROONI, G. B. TOEWS, J. P. LYNCH III, B. H. GROSS, P. N. CASCADE, D. L. SPIZARNY, A. FLINT, M. ANTHONY SCHORK, R. I. WHYTE, et al. Idiopathic Pulmonary Fibrosis . Predicting Response to Therapy and Survival Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1063 - 1072. [Abstract] [Full Text] [PDF]

				A.-L. A. KATZENSTEIN and J. L. MYERS Idiopathic Pulmonary Fibrosis . Clinical Relevance of Pathologic Classification Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1301 - 1315. [Full Text] [PDF]

				P. A. WARD and G. W. HUNNINGHAKE Lung Inflammation and Fibrosis Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S123 - S129. [Full Text] [PDF]

				M. W. ZIEGENHAGEN, P. ZABEL, G. ZISSEL, M. SCHLAAK, and J. MULLER-QUERNHEIM Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 762 - 768. [Abstract] [Full Text] [PDF]

</

				A. U. WELLS, D. M. HANSELL, P. L. HASLAM, M. B. RUBENS, J. CAILES, C. M. BLACK, and R. M. du BOIS Bronchoalveolar Lavage Cellularity . Lone Cryptogenic Fibrosing Alveolitis Compared with the Fibrosing Alveolitis of Systemic Sclerosis Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1474 - 1482. [Abstract] [Full Text]